Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Data availability Individual participant data collected during the trial, after deidentification, the study protocol, statistical analysis plan and the patient information sheet (consent form) can be shared on request
The firm said the most important GLP-1 studies investors should watch are the SYNCHRONIZA-CVOT, REDEFINE-3, and the SURMOUNT-MMO from Boehringer Ingelheim, Novo Nordisk, and Eli Lilly, respectively
Many of the side effects covered in this guide particularly nausea, vomiting, and reflux are directly triggered or worsened by specific foods
A 340B-eligible hospital or outpatient oncology clinic has a direct financial incentive to use the lowest-acquisition-cost biosimilar available
Do not stop taking this medication without consulting your healthcare provider because some conditions may become worse when the drug is suddenly stopped
US$ 25.84
US$ 29.58
US$ 29.47
US$ 28.08
US$ 21.33
